Elehear Alpha vs Lexie B3

The Elehear Alpha is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $299, it sits in the most affordable price tier for over-the-counter devices, though its overall performance ranks #44 of 65 OTC hearing aids tested. This behind-the-ear device presents a distinctive performance profile with notable strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.2/5—a strong result that's 2.28 points above the category average. Feedback handling is also excellent at 5.0/5, meaning users can expect stable performance without whistling issues. However, core speech understanding metrics fall below category norms: speech in quiet scores a mixed 2.1/5 (0.73 points below average), while speech in noise is low at 1.0/5 (0.48 points below average). Own-voice comfort is a significant limitation, scoring just 0.7/5—a low result that's 1.81 points below the category average. This suggests users may experience noticeable occlusion effects when speaking. The Elehear Alpha is best suited for budget-conscious consumers who prioritize music and media streaming over speech clarity in challenging environments. Those needing stronger speech performance should consider alternatives like the Elehear Beyond or Olive Union Air, which offer better sound scores at similar or lower price points. For users primarily streaming podcasts, audiobooks, or music who have modest speech amplification needs, the Alpha's excellent streaming quality and feedback stability may justify its trade-offs.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.